KCNB2 Gene

KCNB2 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNB2 Gene</th>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>20q13.13</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Broad, high in cortex</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Somatic, dendritic</td>
</tr>
<tr>
<td class="label">Gating kinetics</td>
<td>Slower activation</td>
</tr>
<tr>
<td class="label">Regulation</td>
<td>Highly modifiable</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

KCNB2 encodes the voltage-gated potassium channel subunit Kv2.2, a delayed-rectifier channel that helps terminate action potentials and stabilize repetitive firing in excitatory [neurons](/entities/neurons).[@bocksteins2009] Kv2.2 is a close paralog of Kv2.1 (KCNB1), but it has distinct localization and biophysical behavior in several neuronal populations, including cortical and hippocampal circuits.[@bocksteins2009][@hille2001] In NeuroWiki terms, KCNB2 sits in the membrane excitability layer of the gene -> protein -> pathway -> phenotype chain.

Gene And Protein Context

KCNB2 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNB2 Gene</th>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>20q13.13</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Broad, high in cortex</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Somatic, dendritic</td>
</tr>
<tr>
<td class="label">Gating kinetics</td>
<td>Slower activation</td>
</tr>
<tr>
<td class="label">Regulation</td>
<td>Highly modifiable</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

KCNB2 encodes the voltage-gated potassium channel subunit Kv2.2, a delayed-rectifier channel that helps terminate action potentials and stabilize repetitive firing in excitatory [neurons](/entities/neurons).[@bocksteins2009] Kv2.2 is a close paralog of Kv2.1 (KCNB1), but it has distinct localization and biophysical behavior in several neuronal populations, including cortical and hippocampal circuits.[@bocksteins2009][@hille2001] In NeuroWiki terms, KCNB2 sits in the membrane excitability layer of the gene -> protein -> pathway -> phenotype chain.

Gene And Protein Context

KCNB2 is located on chromosome 8 and produces transcripts encoding the alpha subunit of Kv2.2.[@ncbi] Like other Kv channels, Kv2.2 has six transmembrane segments per subunit and assembles as a tetrameric pore-forming complex.[@bocksteins2009] Functional channels can include accessory proteins and can coexist with related delayed-rectifier channels that shape spike width and interspike interval.[@bocksteins2009][@hille2001]

Key points:

• Delayed-rectifier K+ current contributes to repolarization after depolarization.[@bocksteins2009]
• Kv2-family channels influence firing regularity and activity-dependent adaptation.[@bocksteins2009][@hille2001]
• Cellular localization and phosphorylation state can tune channel availability.[@bocksteins2009][@hille2001]

Mechanistic Relevance To Neurodegeneration

Direct KCNB2-specific neurodegeneration literature is still limited compared with KCNB1 and sodium-channel genes. The strongest current framing is mechanistic rather than disease-specific: altered delayed-rectifier function can shift excitability, calcium load, and metabolic demand, all of which are recurrent stress amplifiers in vulnerable neurons.[@bocksteins2009][@hille2001]

This matters in diseases where network hyperexcitability, synaptic failure, or calcium dysregulation are present, including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease). In those contexts, KCNB2 should be viewed as a candidate modifier node in excitability pathways rather than as a confirmed primary driver.[@bocksteins2009][@hille2001]

Human Genetics And Clinical Signal

Recent reports have expanded KCNB2 clinical genetics beyond earlier sparse annotation:

• Monoallelic KCNB2 variants have been associated with neurodevelopmental syndromes featuring epilepsy and developmental delay in newly aggregated cohorts.[@spectorcohen2024]
• Reviews now describe KCNB2 as an emerging potassium-channel neurodevelopmental disease gene, while emphasizing that variant-level interpretation remains critical.[@galfo2024]

Translational Perspective

For current translational work, the most practical role for KCNB2 is in panel-level interpretation:

• Channelopathy and epilepsy-focused genomic panels where excitability genes are co-interpreted.[@spectorcohen2024][@galfo2024]
• Mechanism-first subgrouping of patients with mixed neurodevelopmental and neurodegenerative trajectories.
• Hypothesis generation for network-excitability interventions, especially where electrophysiology suggests delayed-rectifier imbalance.

See Also

• [KCNB2 Protein](/proteins/kcnb2-protein)
• [Ion Channel Dysfunction](/mechanisms/ion-channel-dysfunction-neurodegeneration))
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [NCBI Gene: KCNB2](https://www.ncbi.nlm.nih.gov/gene/3746)
• [UniProt: KCNB2](https://www.uniprot.org/uniprotkb/Q92953)

References

Structural Features

The Kv2.2 channel (encoded by KCNB2) is a member of the voltage-gated potassium channel superfamily, characterized by a tetrameric assembly of four alpha subunits, each containing six transmembrane segments (S1-S6)[@strop2008]. The S4 segment serves as the voltage sensor, containing positively charged residues that move in response to membrane depolarization to initiate channel opening. The pore region, formed by the S5-S6 segments, allows selective permeation of potassium ions.

Key structural features of Kv2.2 include:

• Voltage sensor domain (VSD): The S1-S4 segments form an independent voltage-sensing module that undergoes conformational changes upon membrane depolarization
• Tetramerization domain (T1): The N-terminal T1 domain mediates tetramer assembly and interacts with accessory subunits
• C-terminal regulatory domain: Contains multiple phosphorylation sites and interaction motifs that modulate channel gating
• Proline-rich hinge: The PXP motif in the S6 segment provides flexibility for channel opening and closing

Channel Physiology

Delayed Rectifier Function

Kv2.2 functions as a delayed-rectifier potassium channel, contributing to action potential repolarization and controlling neuronal firing properties[@hille2001]. The delayed-rectifier current (I_K) activates relatively slowly during depolarization and persists throughout the action potential, effectively terminating the spike and enabling the neuron to enter a refractory period.

The kinetics of Kv2.2 include:

• Activation: Moderate speed, reaching half-maximal activation around -10 to +10 mV
• Inactivation: Minimal inactivation, allowing sustained current during repetitive firing
• Deactivation: Relatively fast, enabling rapid return to rest potential

Activity-Dependent Regulation

Kv2 channels are dynamically regulated by neuronal activity through multiple mechanisms[@du2019]:

• Phosphorylation: Multiple serine/threonine phosphorylation sites modulate channel gating, localization, and interaction with accessory proteins[@tu2010]
• Trafficking: Activity-dependent changes in channel distribution between the somatic membrane and intracellular pools
• Alternative splicing: Different splice variants exhibit distinct properties

Role in Neurodegeneration

Excitotoxicity Pathway

Neuronal excitotoxicity is a hallmark of many neurodegenerative conditions, including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease). Potassium channels, including Kv2.2, play critical roles in modulating excitability and calcium influx[@pal2021].

The excitotoxicity connection involves:

Alzheimer'S Disease

In Alzheimer's disease, several studies have implicated Kv2 channel dysfunction[@gu2015]:

• Altered potassium current properties in cortical neurons
• Changes in channel expression and localization
• Contribution to network hyperexcitability observed in AD models

Parkinson'S Disease

Kv2 channels may be affected in dopaminergic neurons:

• Alterations in firing properties of substantia nigra pars compacta neurons
• Modulation ofpacemaker activity and burst firing
• Potential contribution to selective vulnerability

Kv2 Channel Comparisons

Therapeutic Implications

Drug Development Targets

Kv2 channels represent potential therapeutic targets for neurodegenerative diseases[@hernandez2022]:

• Activators: Enhance K+ conductance to reduce excitability
• Blockers: May increase excitability in certain contexts
• Modulators: Activity-dependent regulation through phosphorylation

Clinical Considerations

Current clinical translation faces challenges:

• Channel subtype specificity
• CNS penetration of compounds
• Understanding of disease-specific mechanisms
• Balancing excitability across different neuronal populations

Animal Models

Key research models include:

• Knockout mice: Kcnb2-null mice show altered neuronal excitability
• Transgenic models: Conditional expression to study cell-type specific functions
• iPSC models: Patient-derived neurons with KCNB2 variants

Research Directions

Key open questions include: